Minakem Acquires API Plant from AstraZeneca

Pharmaceutical intermediates and active pharma ingredients (API) manufacturer Minakem (Beuvry-la-Forêt, France) has completed the acquisition of a multi-purpose API plant at Dunkirk, France from AstraZeneca. Minakem says it has also signed a long-term contract with AstraZeneca to supply budesonide, omeprazole, and esomeprazole. Financial details of the deal were not disclosed. The deal brings Minakem significant manufacturing capabilities and raises its custom synthesis capacity, Minakem says. The increased capacity will also help to reduce API costs, the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers